Cosmetic Label Requirements Thailand: A Brand Owner's Checklist

Why the label is a formulation decision, not a design decision

Cosmetics placed on the Thai market are subject to a notification process administered by the Thai FDA, and the label is one of the documents that has to be consistent with what was notified. That consistency requirement is what links the label back to the formula.

Three chains of consequence follow, and each one has cost attached:

• **Your claim determines your formula.** If you want to position the product around a specific effect, the formula needs to be designed and supported accordingly, and supporting evidence takes time and budget. Deciding the claim after the formula is locked usually means either a weaker claim or a reformulation.
• **Your ingredient list determines your claim.** Certain ingredients are restricted or prohibited, and certain combinations limit what can be said. Your formulator knows this; your designer does not.
• **Your label content determines your packaging size.** Mandatory information takes physical space at a legible size. A 10 ml dropper bottle with a long ingredient list and bilingual text can run out of surface before the brand name gets any room, which is how brands end up adding an outer carton or a wrap label late in the process.

The practical move is to draft the label content before you approve the final packaging component, and to share the draft with the manufacturer at the same time you share the design concept. Most **skincare OEM** partners will review it against what they can actually notify, and flag problems while they are still cheap to fix. The same applies when you are working across formats — a cream, a serum and a sachet in the same line may each need a different solution to the same space problem.

The information blocks a Thai cosmetic label is built around

Exact requirements are set out in Thai regulations and are updated periodically, so confirm the current list with the Thai FDA or a regulatory consultant before you print. What follows is the structure the regulations are organised around, which is stable enough to plan with.

• **Product identity.** The product name and the type of cosmetic, so a buyer and an inspector can tell what it is.
• **Ingredient declaration.** A full list of ingredients, generally in descending order of quantity with conventions for low-percentage ingredients, using internationally recognised ingredient nomenclature rather than marketing names.
• **Net content.** The quantity in the package, expressed in metric units.
• **Batch or lot identification.** So a specific production run can be traced.
• **Manufacturing and expiry information.** Dates presented in the format required, which is a frequent source of error for exporters because of calendar conventions.
• **Manufacturer and responsible party.** The name and location of the manufacturer, and of the importer or party responsible for placing the product on the market.
• **Directions for use and warnings.** Including any category-specific warnings that apply to the ingredients present.
• **The notification reference.** The identifier issued through the notification process.

Notice how much of this comes from the manufacturer rather than from you. The batch code format, the ingredient declaration and the manufacturer details are theirs; the brand name, the directions wording and the layout are yours. A clean division of responsibility in the artwork brief prevents the common failure where both sides assume the other is filling a field.

Plan the artwork around these blocks first, then fit the brand design around them, not the reverse.

Language, legibility and the physical constraints

Regulations in this area generally address not only what information appears but whether an ordinary buyer can read it. Two products with identical content can fail at different points if one is printed at a size nobody can read.

Planning points that come up in almost every project:

• **Language.** Products sold in Thailand are expected to carry the required information in Thai. Products manufactured in Thailand for export are a different case, governed by the destination market's rules. If one SKU is intended for both, you are designing a bilingual label and you need to allocate the space for it from the first layout.
• **Minimum legible size.** Small print has practical limits. On small primary packaging this is the single most common reason a layout has to change.
• **Contrast and finish.** Text printed in a close tone on a textured or metallic surface can become effectively unreadable. Check a physical proof, not a screen.
• **Surface available.** A tube has a printable area smaller than its total surface because of the seal and the shoulder. A dropper bottle loses area to curvature. Ask for the printable dieline from your manufacturer before designing, not after.
• **Where the information sits.** Some information is expected to be visible without opening the package.

When the information will not fit, the usual answers are an outer carton, a leaflet where permitted, or a peel-and-reveal multi-layer label. Each adds cost and adds a component with its own production rhythm. Brands running a line that spans **home care OEM** formats as well as cosmetics often standardise on one solution across the range, because managing three different label constructions is a recurring source of delay.

Whatever you choose, confirm the approach with your manufacturer and your regulatory adviser before committing to the component.

Ingredient naming and the limits on claims

Two areas cause more rework than anything else: how ingredients are named, and how benefits are worded.

**Ingredient naming.** Ingredient declarations use standardised international nomenclature, not the names used in marketing. The extract you call Thai rice bran on the front of the pack appears under its standardised botanical name in the list. This creates a trap: brand owners sometimes feature an ingredient prominently on the front while it sits far down the list in a small quantity. That mismatch is noticeable and undermines trust even where it is permissible.

**Claims.** The line that matters most is between a cosmetic claim and a claim that implies a therapeutic or medicinal effect. Cosmetics are regulated as cosmetics; wording that suggests a product treats, prevents or cures a condition moves it toward a different regulatory category with substantially different requirements. Comparative and superlative wording, and anything implying a guaranteed outcome, also carries risk.

Safer wording patterns that still sell:

• Describe what the user experiences — texture, finish, scent, how the skin feels after use.
• Describe the ritual rather than the result — when and how it is used in a routine.
• Attribute an effect to the product only where you hold supporting evidence appropriate to the claim.
• Where the evidence is a consumer perception study, make the basis clear rather than implying a clinical finding.

This boundary matters even more when a brand runs both cosmetic and ingestible lines. A business doing **beauty supplement OEM** alongside skincare is dealing with two different regulatory frameworks, two different claim vocabularies and two different notification or registration routes. Keep the copy decks separate, and have each reviewed by someone who knows the relevant framework. Because interpretation evolves, run final wording past the Thai FDA or a regulatory consultant before printing.

Export labels: one product, several markets

Many brands manufacturing in Thailand sell in several markets. Each destination has its own label rules, its own language requirements, its own restricted ingredient list and its own view on claims. Pretending otherwise produces expensive surprises.

Three workable strategies, each with trade-offs:

• **A single global label.** One artwork that satisfies the strictest requirements across your target markets, usually multilingual and dense. Lowest component complexity and best unit economics, but the hardest to design and the slowest to approve, and you inherit every market's restrictions even in markets that do not impose them.
• **A base label plus market-specific overlay.** A core printed label carrying universal content, with an additional local-language label applied for each destination. Flexible and common in practice, but adds an application step and a risk of the overlay covering required information.
• **Separate artwork per market.** Cleanest result and best brand presentation, highest minimum order commitment across components, and the most version control work. Usually makes sense only once volumes per market justify it.

Whichever you choose, tell your manufacturer the full destination list at the briefing stage. It affects ingredient selection — an ingredient permitted in one market may be restricted in another — and reformulating after the first production run is far more expensive than selecting a compliant raw material at the start.

One scheduling note that catches first-time brands: components and finished product run on separate lead times. Labels, cartons and primary packaging each have their own production cycle, and in OEM work the standard order quantity is 1,000 units per SKU, which applies per label version too. A three-market split can therefore multiply your committed volume if you choose separate artwork per market. Model that before you decide.

A label sign-off workflow that prevents reprints

Reprints are almost always process failures rather than design failures. This sequence removes most of them.

1. **Lock the product definition.** Formula, size, packaging component and destination markets. Any change after this point reopens the label. 2. **Collect the manufacturer-owned fields in writing.** Full ingredient declaration in standardised nomenclature, net content, manufacturer details, batch code format, date format and any mandatory warnings for the formula. Get this as a document, not as a message in a chat thread. 3. **Draft the brand-owned copy.** Product name, directions, marketing lines, shop and contact details. Keep the marketing claims in a separate list so they can be reviewed on their own. 4. **Run a regulatory review.** Have the claims and the mandatory content checked against current requirements for each destination market, by your manufacturer's regulatory team or an independent consultant. 5. **Lay out on the real dieline.** Use the printable area supplied by the component supplier, at final size, with the real minimum text sizes. 6. **Produce a physical proof.** On the actual substrate with the actual finish. Read it at arm's length in ordinary light. Screens flatter small type. 7. **Sign off on a single controlled file.** One person approves, one file version is released to print, and the version number appears somewhere on the artwork for traceability. 8. **Archive everything.** The approved file, the regulatory review, and the ingredient declaration version it was built from. When you reorder in a year, you will need to know which formula version the label matches.

This workflow is identical whether the product is a cream, a serum, or a powder sachet from a **health supplement OEM** line — only the regulatory framework in step four changes. Teams that build it into their project plan from the briefing stage spend far less time firefighting than teams that treat artwork as the final sprint. The same discipline carries over into **supplement manufacturing** work, where batch traceability expectations tend to be stricter still.